•  
  •  
  •  
  •  

2025-11-16 08:35:48

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Karnataka Bank appoints Veteran Banker Mr Raghavendra S Bhat as its New Managing Director & CEO
  • Websol signs MoU with Andhra Pradesh Economic Development Board
  • Sellwin Traders Ltd has signed MOU to acquire 36% Equity Stake in Kumkum Wellness
  • Western Carriers Reports Q2 & H1 FY26 Results
  • Lupin announces closure of Inspection by U.S. FDA at its Nagpur Unit-1 Facility with No Observations

Keywords Selected:  Inspection

Stock Report

  • Aurobindo Pharma gets 9 observations from USFDA for Unit 2 of Eugia Pharma Specialities Ltd
  • USFDA inspects Unit 1 of Divi's Laboratories Limited
  • Closure of USFDA inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Lupin Bioresearch Center receives Zero Observations from U.S. FDA after Successful Inspection and Assessment
  • Innova Captab Limited updates on SMDC inspection
  • Biocon Limited updates on GMP inspection by USFDA at its Cranbury, New Jersey facility
  • Lupin gets one observation from USFDA for Somerset, New Jersey manufacturing facility
  • Emcure Pharmaceuticals Ltd completes surveillance inspection by USFDA without any observation
  • Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Observations
  • Lupin gets 4 observations from USFDA from PAI at Pune Biotech facility
  • USFDA successfully completes inspection at Indoco's API manufacturing facility at Patalganga with zero observations
  • Lupin receives 6 observations from USFDA for Nagpur Injectable facility
  • Tyche Industries Ltd completes GMP inspection by ANVISA
  • USFDA conducts product specific pre-approval inspection at Lupin Ltd's Aurangabad facility
  • Closure of USFDA inspection at Zydus' injectable manufacturing plant at Jarod
  • U.S. FDA Completes Inspection at Biocon Biologics' Facility at Biocon Campus, Bengaluru, India
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • Concord Biotech Ltd announces successful completion EU GMP inspection at its API facility
  • EIR from USFDA, for Shilpa Medicare Ltd. Unit VI, Bengaluru.
  • Shilpa Pharma Lifesciences Limited, Unit-1, ANVISA Audit from Brazil
  • Granules India Ltd receives 1 observation from USFDA for Chantilly facility
  • SMS Pharmaceuticals Ltd successfully completes USFDA inspection at Central Laboratory Analytical Services

Latest Post

  • Karnataka Bank appoints Veteran Banker Mr Raghavendra S Bhat as its New Managing Director & CEO
  • Websol signs MoU with Andhra Pradesh Economic Development Board
  • Sellwin Traders Ltd has signed MOU to acquire 36% Equity Stake in Kumkum Wellness
  • Western Carriers Reports Q2 & H1 FY26 Results
  • Lupin announces closure of Inspection by U.S. FDA at its Nagpur Unit-1 Facility with No Observations


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024